017 — Ilaris for Gout, Generics for ADHD, Balversa for Urothelial Cancer, INO-3107 for Recurrent Respiratory Papillomatosis, Crovalimab for PNH

Check out our free downloads: Implementing AMA Style – 8 Things to Get Right in Your Next Project Needs Assessments – 7 Essentials for Getting Funded Working With Your Medical…

Continue Reading017 — Ilaris for Gout, Generics for ADHD, Balversa for Urothelial Cancer, INO-3107 for Recurrent Respiratory Papillomatosis, Crovalimab for PNH

016 — New MS Biosimilar, RSV Maternal Immunization, Rybrevant in Advanced NSCLC, Xtandi in Early PCa

Check out our free downloads:Implementing AMA Style – 8 Things to Get Right in Your Next ProjectNeeds Assessments – 7 Essentials for Getting FundedWorking With Your Medical Writer – 8…

Continue Reading016 — New MS Biosimilar, RSV Maternal Immunization, Rybrevant in Advanced NSCLC, Xtandi in Early PCa

015 — Myeloma Bispecific, Uveal Melanoma, HD Eylea, Huntington’s, Fibrodysplasia Ossificans Progressive, CHAPLE Disease

Check out our free downloads at nascentmc.com: Implementing AMA Style – 8 Things to Get Right in Your Next Project Needs Assessments – 7 Essentials for Getting Funded Working With…

Continue Reading015 — Myeloma Bispecific, Uveal Melanoma, HD Eylea, Huntington’s, Fibrodysplasia Ossificans Progressive, CHAPLE Disease

014 — PCa Combo Pill, Multiple Myeloma BiTE, Geographic Atrophy, POLARx for AFib

Check out our free downloads at nascentmc.com: Implementing AMA Style – 8 Things to Get Right in Your Next Project Needs Assessments – 7 Essentials for Getting Funded Working With…

Continue Reading014 — PCa Combo Pill, Multiple Myeloma BiTE, Geographic Atrophy, POLARx for AFib

013 — Post-Partum Depression, Endometrial Cancer, mCRC, and Ebolavirus

Here is information on the latest US FDA approvals, the week of July 31 – August 4, 2023. Zurzuvae, the First-Ever Pill for Post-Partum DepressionThe FDA has granted approval of…

Continue Reading013 — Post-Partum Depression, Endometrial Cancer, mCRC, and Ebolavirus

007 — Talzenna, Elevidys, Jardiance, Litfulo, Blincyto, Vyvgart Hytrulo, Ultravist

Here is information on the latest US FDA approvals, the week of June 19 –  June 23, 2023. Please subscribe, rate and review this podcast. Thank you!Talzenna® plus Xtandi® for…

Continue Reading007 — Talzenna, Elevidys, Jardiance, Litfulo, Blincyto, Vyvgart Hytrulo, Ultravist